The content on this site is intended for healthcare professionals only
Prof Porter talks to ecancer at the European Haematology Association meeting in Amsterdam June 2012. Iron overload can cause death when patients have survived other diseases such as cancer.
Progress has been made in to understanding the molecular processes behind haemochromatosis and new MRI techniques allow clear imaging.
Individuals at the greatest risk of iron overload can now be identified and given personalised treatment accordingly.
Dr Porter looks at upcoming tools for assessing iron overload and covers iron level issues in myelodysplastic syndrome (MDS).
Filming supported by Amgen
New classification for identifying HR myeloma based on cytogenetic abnormalities
Made to measure: Choosing the optimal regimen in transplant-eligible NDMM
Multiple Myeloma: evolving paradigm - Panel Discussion
Advancements in paediatric Acute lymphoblastic leukemia management
Choosing 1st line TKI Wisely in patients with CML
Multiple myeloma In Rwanda: The need for further research
Addressing the rise of multiple myeloma in Rwanda
Isatuximab in combination with pomalidomide and dexamethasone shows promising efficacy in 2nd line RRMM
ELCC 2024: Latest in EGFR mutant lung cancer; exon 20 mutation focus
